Saber CEO Matthew Karch, whose company used to be part of Embracer alongside Volition, explains what happened to the defunct ...

Which is certainly a look.

Karch says that Saints Row is too expensive and "The days of throwing money at games other than maybe the GTAs of the world ...

Saints Row studio Volition shut down in 2023 after 30 years, leading many to wonder about the future of the open-world crime ...

Matt Karch, CEO of Saber Interactive, recently addressed the closure of Volition. The Saints Row developer shuttered its doors in 2023, around a year after it released the poorly received reboot of ...

The CEO of Saber Interactive has some pretty damning words to say about 2022's poorly received Saints Row reboot, and its developer Volition.

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announced the expansion of its Nu.Q® Vet Cancer Test supply agreement (the "Agreement") with Fujifilm ...

VolitionRx (VNRX) announced the expansion of its Nu.Q Vet Cancer Test supply agreement with Fujifilm Vet Systems in Japan, to include ...

"The Nu.Q® Cancer test could support physicians with clinical decision-making following LDCT by identifying the patients at highest risk and whose nodules are more likely to be cancerous, while ...

HENDERSON, Nev., Feb. 28, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, Volition is pleased to announce our participation in the ...

Volition a multi-national epigenetics company, announces its first commercial sale of Volition's High Throughput Synthetic Sepsis method that measures Neutrophil Extracellular Traps "NETs" activation ...

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces that it has signed an agreement with a leading pharmaceutical company to utilize Volition's ...